News

NBS-101 is being studied as an improved tablet formulation of strontium, which was recently approved in Europe, in the form of strontium ranelate, and launched in several European

The multi-center study will assess the safety, tolerability, pharmacokinetics and viral response to daily subcutaneous administration of AVI-4065 among healthy volunteers and patients with chronic active hepatitis C

The FDA has ceased its review of the application, based on its concerns related to the higher drug content in the Noven generic product versus the branded Duragesic

The concerns are based on a study that showed a 4% incidence of birth defects in children whose mothers took Paxil during the first trimester of pregnancy, compared

Shares in Incyte have been hit hard, tumbling over 40% in the wake of the news. The extra trial is likely to represent a delay in the drug’s

The first study of its kind in the US, this multi-center, randomized trial will compare degenerative disc disease patients who receive the Wallis implant to those who are

To date, more than 200 patients have been treated with velafermin in this trial, and the last patient is expected to be enrolled by the end of September.

Eisai also will assume responsibility for post-marketing studies and product distribution, as well as book all US sales. According to this agreement, Pfizer will transfer the new drug

In the study the stem cells differentiated into cells displaying the characteristics of nucleus pulposus that forms the soft gel-like center of an intervertebral disc that is adversely